These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3377765)

  • 1. Activation of heparin cofactor II by heparin oligosaccharides.
    Maimone MM; Tollefsen DM
    Biochem Biophys Res Commun; 1988 May; 152(3):1056-61. PubMed ID: 3377765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin-inhibitory activity of whale heparin oligosaccharides.
    Ototani N; Kodama C; Kikuchi M; Yosizawa Z
    J Biochem; 1984 Dec; 96(6):1695-703. PubMed ID: 6530392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.
    Bray B; Lane DA; Freyssinet JM; Pejler G; Lindahl U
    Biochem J; 1989 Aug; 262(1):225-32. PubMed ID: 2818566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a unique sequence in heparin for interaction with heparin cofactor II? Structural and biological studies of heparin-derived oligosaccharides.
    Petitou M; Lormeau JC; Perly B; Berthault P; Bossennec V; Sié P; Choay J
    J Biol Chem; 1988 Jun; 263(18):8685-90. PubMed ID: 3379040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II.
    Tollefsen DM; Peacock ME; Monafo WJ
    J Biol Chem; 1986 Jul; 261(19):8854-8. PubMed ID: 3755134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulantly active heparin-like molecules from cultured fibroblasts.
    Marcum JA; Conway EM; Youssoufian H; Rosenberg RD
    Exp Cell Res; 1986 Sep; 166(1):253-8. PubMed ID: 3743657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic effects of heparin oligosaccharides.
    Mattsson C; Palm M; Söderberg K; Holmer E
    Ann N Y Acad Sci; 1989; 556():323-32. PubMed ID: 2735663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the molecular mass dependency of heparin stimulation of heparin cofactor II:thrombin interaction to antithrombin III:thrombin interaction.
    Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1987 May; 46(3):491-502. PubMed ID: 3603437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.
    Lane DA; Denton J; Flynn AM; Thunberg L; Lindahl U
    Biochem J; 1984 Mar; 218(3):725-32. PubMed ID: 6721831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low molecular weight heparin preparations on the inhibition of thrombin by heparin cofactor II.
    Tollefsen DM; Sugimori T; Maimone MM
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():66-70. PubMed ID: 1962908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentosan polysulphate: activation of heparin cofactor II or antithrombin III according to molecular weight fractionation.
    Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1986 Feb; 41(4):489-99. PubMed ID: 2421433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search for the heparin antithrombin III-binding site precursor.
    Linhardt RJ; Wang HM; Loganathan D; Bae JH
    J Biol Chem; 1992 Feb; 267(4):2380-7. PubMed ID: 1733939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin cofactor II is degraded by heparan sulfate and dextran sulfate.
    Saito A
    Biochem Biophys Res Commun; 2015 Feb; 457(4):585-8. PubMed ID: 25600805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatan sulfate and heparin can be fractionated by affinity for heparin cofactor II.
    Griffith MJ; Marbet GA
    Biochem Biophys Res Commun; 1983 Apr; 112(2):663-70. PubMed ID: 6687802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant activity of heparin octasaccharide.
    Ototani N; Yosizawa Z
    J Biochem; 1981 Nov; 90(5):1553-6. PubMed ID: 7338523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
    Halldórsdóttir AM; Zhang L; Tollefsen DM
    Glycobiology; 2006 Aug; 16(8):693-701. PubMed ID: 16624894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural features of heparin and their effect on heparin cofactor II mediated inhibition of thrombin.
    Kim YS; Linhardt RJ
    Thromb Res; 1989 Jan; 53(1):55-71. PubMed ID: 2922702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and structure of heparin lyase-derived heparan sulfate oligosaccharides.
    Hileman RE; Smith AE; Toida T; Linhardt RJ
    Glycobiology; 1997 Mar; 7(2):231-9. PubMed ID: 9134430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanism.
    O'Keeffe D; Olson ST; Gasiunas N; Gallagher J; Baglin TP; Huntington JA
    J Biol Chem; 2004 Nov; 279(48):50267-73. PubMed ID: 15371417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consumption of heparin cofactor II (dermatan sulfate cofactor) and antithrombin during coagulation.
    Andersson TR
    Thromb Res; 1987 Apr; 46(2):355-62. PubMed ID: 3603428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.